LYN-005

Lyndra Therapeutics' Once-Per-Week Schizophrenia Treatment Shines in Phase II
BioSpace
Mon, 04/19/21 - 10:28 pm
Lyndra Therapeutics
schizophrenia
clinical trials
LYN-005